Literature DB >> 6394062

A comparison of reflected versus test-based confidence intervals for the median survival time, based on censored data.

E V Slud, D P Byar, S B Green.   

Abstract

The small-sample performance of some recently proposed nonparametric methods of constructing confidence intervals for the median survival time, based on randomly right-censored data, is compared with that of two new methods. Most of these methods are equivalent for large samples. All proposed intervals are either 'test-based' or 'reflected' intervals, in the sense defined in the paper. Coverage probabilities for the interval estimates were obtained by exact calculation for uncensored data, and by stimulation for three life distributions and four censoring patterns. In the range of situations studied, 'test-based' methods often have less than nominal coverage, while the coverage of the new 'reflected' confidence intervals is closer to nominal (although somewhat conservative), and these intervals are easy to compute.

Mesh:

Year:  1984        PMID: 6394062

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   2.571


  5 in total

1.  Nonparametric quantile estimation with correlated failure time data.

Authors:  Jianwen Cai; Jinheum Kim
Journal:  Lifetime Data Anal       Date:  2003-12       Impact factor: 1.588

2.  Value of infliximab (Remicade®) in patients with low-risk myelodysplastic syndrome: final results of a randomized phase II trial (EORTC trial 06023) of the EORTC Leukemia Group.

Authors:  Frédéric Baron; Stefan Suciu; Sergio Amadori; Petra Muus; Heinz Zwierzina; Claudio Denzlinger; Michel Delforge; Antoine Thyss; Dominik Selleslag; Karel Indrak; Gert Ossenkoppele; Theo de Witte
Journal:  Haematologica       Date:  2011-11-18       Impact factor: 9.941

3.  Use of glycosylated recombinant human G-CSF (lenograstim) during and/or after induction chemotherapy in patients 61 years of age and older with acute myeloid leukemia: final results of AML-13, a randomized phase-3 study.

Authors:  Sergio Amadori; Stefan Suciu; Ulrich Jehn; Roberto Stasi; Xavier Thomas; Jean-Pierre Marie; Petra Muus; Francois Lefrère; Zwi Berneman; George Fillet; Claudio Denzlinger; Roel Willemze; Pietro Leoni; Giuseppe Leone; Marco Casini; Francesco Ricciuti; Marco Vignetti; Filip Beeldens; Franco Mandelli; Theo De Witte
Journal:  Blood       Date:  2005-03-10       Impact factor: 22.113

4.  Combining one-sample confidence procedures for inference in the two-sample case.

Authors:  Michael P Fay; Michael A Proschan; Erica Brittain
Journal:  Biometrics       Date:  2014-10-01       Impact factor: 2.571

5.  New validated prognostic models and prognostic calculators in patients with low-grade gliomas diagnosed by central pathology review: a pooled analysis of EORTC/RTOG/NCCTG phase III clinical trials.

Authors:  Thierry Gorlia; Wenting Wu; Meihua Wang; Brigitta G Baumert; Minesh Mehta; Jan C Buckner; Edward Shaw; Paul Brown; Roger Stupp; Evanthia Galanis; Denis Lacombe; Martin J van den Bent
Journal:  Neuro Oncol       Date:  2013-09-18       Impact factor: 12.300

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.